Discover the joys of crafting your very own DIY terrarium and transform your space into a green oasis! Whether this is your first time or you are a crafty botanical enthusiasts, this virtual workshop ...

En esta información se explica qué son el síndrome de liberación de citocinas y el síndrome de neurotoxicidad. También se describen las causas, los síntomas y los tratamientos comunes de cada enfermed ...

En esta información se explican las pautas alimentarias (comida y bebida) que necesitará seguir después de su balón gástrico (gastroyeyunostomía) o el procedimiento de Whipple (duodenopancreatectomía) ...

Researchers from Memorial Sloan Kettering Cancer Center (MSK) reported important advances in the treatment of lung cancer at the annual meeting of the American Society of Clinical Oncology (ASCO), ...

More than three decades ago, the U.S. Food and Drug Administration (FDA) approved Bacillus Calmette-Guérin (BCG) as the first immunotherapy against cancer. And it is still used today to treat ...

Results of the Phase 2 Trial for Avutometinib-Defactinib Combination Ellen is not the only patient to respond well to the treatment. Overall, 44% of patients with a KRAS mutation in the phase 2 trial ...

An approach pioneered at Memorial Sloan Kettering Cancer Center (MSK) that caused rectal cancer tumors with a specific genetic mutation to disappear in 100% of clinical trial participants has been ...

MSK’s History of Stem Cell Research for Parkinson’s The phase 3 trial is the culmination of research going back 25 years, when Dr. Studer first came to MSK and began investigating embryonic stem cells ...

Enhancing MSK Innovation With support from AWS, MSK also aims to expand its Innovation Hub, its startup ecosystem, and its AI-enabled drug discovery efforts. MSK Innovation Hub: MSK’s Innovation Hub ( ...

Funding and Disclosures: This work was supported by the Sandler Family (via the Jewish Communal Trust), the MSKCC Technology Development Fund, and the Fondation ARC Léopold Griffuel Award. This ...

Doctors at Memorial Sloan Kettering Cancer Center (MSK) pioneered advances in a variety of cancer treatments in 2024 — including new surgical techniques, innovative cancer vaccines, drugs to boost ...

Lung cancer is the second-most common cancer and remains the leading cause of cancer death in the United States. But a variety of new treatments, many of them developed or tested at Memorial Sloan ...